Lazard Asset Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Buy |
25,436
+1,309
| +5% | +$124K | ﹤0.01% | 952 |
|
|
2025
Q1 | $1.53M | Sell |
24,127
-10,376
| -30% | -$658K | ﹤0.01% | 1055 |
|
|
2024
Q4 | $1.6M | Buy |
34,503
+9,267
| +37% | +$430K | ﹤0.01% | 961 |
|
|
2024
Q3 | $726K | Buy |
+25,236
| New | +$726K | ﹤0.01% | 1233 |
|
|
2023
Q3 | – | Sell |
-37,136
| Closed | -$785K | – | 2496 |
|
|
2023
Q2 | $785K | Buy |
+37,136
| New | +$785K | ﹤0.01% | 1031 |
|